New York, NY (PRWEB) April 24, 2013
The first set of guidelines ever offered to medical professionals treating schizophrenia that align the many competing worldwide standards as a new “guideline of guidelines” has been launched by an international team of experts.
The team, drawn from a range of universities and hospitals, has collaborated to make these guidelines the definitive resource for clinicians treating patients across the full spectrum of the condition, from stable through to acute phases.
Available in the latest issue of CNS Spectrums, the journal of the Neuroscience Education Institute, “ ‘Meta-guidelines’ for the management of patients with schizophrenia” covers every weapon in the medical professional’s armory, from pastoral treatments such as therapy through to technological aids like brain imaging and the full range of medications available to help patients control their condition. The journal is published by Cambridge University Press.
The guidelines also help clinicians to choose the most evidence-based and up-to-date strategies for determining the right treatment, addressing side effects of medication and other issues commonly encountered in treating patients with schizophrenia.
They are the brainchild of US clinician, researcher, and teacher in psychiatry Dr. Stephen M. Stahl, who put together the team that produced them. Stahl brought in experts from the Universities of California, Texas and Cambridge (UK), California’s Neuroscience Education Institute, the California Department of State Hospitals, the New York Medical College and the Texas-based San Antonio State Hospital.
Stahl said: “Schizophrenia is one of the most challenging conditions to treat and, up until now, there has been no definitive set of guidelines to help doctors, nurses and other health professionals to judge what a patient needs at any stage of their illness. What has been available is a confusing mix of several sets of guidelines from different countries, experts, and settings. Often these recommendations contradict one another and are quickly out of date.
“What this expert team has now provided is a ‘guideline of guidelines’, or ‘meta-guidelines’, which bring together the various existing standards and update them with current best practice and new medication. We are confident they will benefit anyone working in the field anywhere across the world.”
The guidelines are intended for rank-and-file patients with schizophrenia who are not violent or self-harming and do not have other medical problems along with their condition. Stahl says the team is now working on providing a similar set of meta-guidelines for the treatment of these more complex cases.
The guidelines are available at: http://journals.cambridge.org/CNSguidelines
Notes to Editors:
For further information or to arrange interviews please contact Susan Soule, Journals Marketing Manager, Cambridge University Press using the following details:
About CNS Spectrums
The journal brings clinical research and information to 50,000 psychiatrists and neurologists. Launched in 1996 and relaunched in 2012 with a new Editor-in-Chief, Dr. Stephen M. Stahl, and an entirely new editorial board, CNS Spectrums reaches more physicians than any other peer-reviewed neuropsychiatric journal in the world. The journal’s goal is to serve as a resource for psychiatrists and neurologists seeking to understand and treat disturbances of cognition, emotion, and behavior as a direct consequence of central nervous system disease, illness, or trauma.
For further information, go to: http://journals.cambridge.org/CNS
About Dr. Stephen M. Stahl
Dr. Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California and the author of best-selling textbook Essential Psychopharmacology, now in its fourth edition, as well as the best-selling clinical manual, Essential Psychopharmacology Prescriber's Guide. Stahl is an internationally-renowned clinician, researcher, and teacher in psychiatry.
About the Neuroscience Education Institute
Founded in 2000 by Dr. Stephen M. Stahl, the NEI provides interactive learning to mental health clinicians and neuroscientists. Through NEI's annual Psychopharmacology Congress, its web-based activities, and its online resources, NEI simplifies complex concepts to enhance understanding. NEI Members and Guests have access to this online resource focused on the essentials of psychopharmacology.
For further information, go to: http://www.neiglobal.com
About Cambridge Journals
Cambridge University Press publishes over 300 peer-reviewed academic journals across a wide spread of subject areas, in print and online. Many of these journals are the leading academic publications in their fields and together they form one of the most valuable and comprehensive bodies of research available today.
For further information, go to: http://journals.cambridge.org
About Cambridge University Press
Cambridge University Press is the publishing business of the University of Cambridge. Dedicated to excellence, its purpose is to further the University's objective of advancing knowledge, education, learning, and research.
Its extensive peer-reviewed publishing lists comprise 45,000 titles covering academic research, professional development, over 300 research journals, school-level education, English language teaching and bible publishing.
Playing a leading role in today’s international market place, Cambridge University Press has more than 50 offices around the globe, and distributes its products to nearly every country in the world.
For further information, go to: http://www.cambridge.org